Form 4: Mainz Biomed Director Receives Stock Grant
Insider Transaction (Form 4)
Avraham Ben-Tzvi, a Director of Mainz Biomed N.V., received 112,259 shares of common stock on July 31, 2026.
Summary
- Grant/award: acquired 112,259 Ordinary Shares on July 31, 2026; holds 251,400 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Avraham Ben-Tzvi — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-31 | Grant/award | Ordinary Shares | 112,259 | — | — | 251,400 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-31 | Grant/award (112,259 shares) |
Keywords
insider transaction, Form 4, QUCY, Quantum Cyber N.V., neutral, Avraham Ben-Tzvi
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.